# KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)

> **NCT03065244** · PHASE3 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 105 (actual)

## Conditions studied

- Mucocutaneous Lymph Node Syndrome

## Interventions

- **DRUG:** IVIG
- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT03065244
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-17
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-11-02
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2021-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03065244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03065244, "KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03065244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*